Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software
solutions and Myrian® designer provides an update on its development strategy
following its successful capital increase in June 2021.

Intrasense today announced the success of its capital increase through the issuance of new shares (“New Shares”) with shareholders’ preferential subscription rights, for which subscriptions took place between May 28 and June 15, 2021 (the “Rights Issue”).

Intrasense launch a capital increase through the issuance of new shares with shareholders’ preferential subscription rights. 

Intrasense today announces the publication of its annual financial report for the financial year ended on December 31, 2020.

Intrasense and Vidi, the leading cooperative network of medical imaging groups in France, signed an agreement on January 30th, 2021 to reference Myrian® solutions.

Intrasense is pleased to present the new version 2.9, with a focus on new clinical features.

Intrasense announces its 2020 IFRS Group consolidated annual results.

Intrasense and MeVis Medical Solutions AG specialized in
the development of clinical applications integrating artificial intelligence, announce a global partnership in the field of lung diseases.

Intrasense announces the publication of its half year liquidity contract signed with TSAF – Tradition Securities And Futures.

Intrasense strengthens its management team with the appointment of Khalil Filali as Group Chief Business Officer.